Who
Christoph Lawrence Bausch
Chief Operating Officer
Company insider
Files Form 4 as: Chief Operating Officer, SAB Biotherapeutics.
In numbers
- Trades disclosed
- 15
- Buys
- 0
- Sells
- 0
- Bought
- $0
- Sold
- $0
- Companies
- 1
- Companies where not an officer
- 0
- First trade
- 22 Oct 2021
- Last trade
- 3 Feb 2026
- Last filed
- 5 Feb 2026
Companies traded
Activity over time
Not enough dated trades to draw.
Every trade
| Traded | Company | What | Amount | |
|---|---|---|---|---|
| 3 Feb 2026filed 5 Feb 2026 | SABS SAB Biotherapeuticsoption or derivative · Biotechnology | SEC FORM 4 Code A | —1,800,000 at $0.00 | filing |
| 3 Feb 2026filed 5 Feb 2026 | SABS SAB Biotherapeuticsoption or derivative · Biotechnology | SEC FORM 4 Code A | —1,800,000 at $0.00 | filing |
| 26 Aug 2025filed 28 Aug 2025 | SABS SAB Biotherapeuticsoption or derivative · Biotechnology | SEC FORM 4 Code A | —600,000 at $0.00 | filing |
| 21 Feb 2024filed 23 Feb 2024 | SABS SAB Biotherapeuticsoption or derivative · Biotechnology | SEC FORM 4 Code A | —140,000 at $0.00 | filing |
| 14 Mar 2023filed 16 Mar 2023 | SABS SAB Biotherapeuticsoption or derivative · Biotechnology | SEC FORM 4 Code A | —275,000 at $0.00 | filing |
| 13 Sep 2022filed 15 Sep 2022 | SABS SAB Biotherapeuticsoption or derivative · Biotechnology | SEC FORM 4 Code A | —274,875 at $0.00 | filing |
| 16 Mar 2022filed 18 Mar 2022 | SABS SAB Biotherapeuticsoption or derivative · Biotechnology | SEC FORM 4 Code A | —24,972 at $0.00 | filing |
| 22 Oct 2021filed 24 Nov 2021 | SABS SAB Biotherapeuticsoption or derivative · Biotechnology | SEC FORM 4 Code A | —104,689 | filing |
| 22 Oct 2021filed 24 Nov 2021 | SABS SAB Biotherapeuticsoption or derivative · Biotechnology | SEC FORM 4 Code A | —81,425 | filing |
| 22 Oct 2021filed 24 Nov 2021 | SABS SAB Biotherapeuticsoption or derivative · Biotechnology | SEC FORM 4 Code A | —108,086 | filing |
| 22 Oct 2021filed 26 Oct 2021 | SABS SAB Biotherapeuticsoption or derivative · Biotechnology | SEC FORM 4 Code A | —104,689 | filing |
| 22 Oct 2021filed 26 Oct 2021 | SABS SAB Biotherapeuticsoption or derivative · Biotechnology | SEC FORM 4 Code A | —81,425 | filing |
| 22 Oct 2021filed 26 Oct 2021 | SABS SAB Biotherapeuticsoption or derivative · Biotechnology | SEC FORM 4 Code A | —69,793 | filing |
| 22 Oct 2021filed 26 Oct 2021 | SABS SAB Biotherapeuticsoption or derivative · Biotechnology | SEC FORM 4 Code A | —11,632 | filing |
| 22 Oct 2021filed 26 Oct 2021 | SABS SAB Biotherapeuticsoption or derivative · Biotechnology | SEC FORM 4 Code A | —108,086 | filing |
News
No headline names them, or the companies they trade most, lately.
Sectors
No trade we could place in a sector.